These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28868023)

  • 1. Next-Generation Sequencing in Order to Better Characterize a BRCA Variant of Uncertain Significance.
    Sorscher S; Ramkissoon S
    Case Rep Oncol; 2017; 10(2):634-637. PubMed ID: 28868023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The implications of BRCA loss of heterozygosity (LOH) and deficient mismatch repair gene (dMMR) expression in the breast cancer of a patient with both inherited breast and ovarian cancer syndrome (BRCA2) and Lynch syndrome (MLH1).
    Sorscher S; Ansley K; Delaney SD; Ramkissoon S
    Breast Cancer Res Treat; 2020 Apr; 180(2):511-514. PubMed ID: 32040686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Importance of Distinguishing Sporadic Cancers from Those Related to Cancer Predisposing Germline Mutations.
    Sorscher S
    Oncologist; 2018 Nov; 23(11):1266-1268. PubMed ID: 29866945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Progression of Metastatic Pancreatic Adenocarcinoma During Platinum-Based Therapy in a Patient Harboring a Pathogenic BRCA2 Germline Variant.
    Sorscher S; Ramkissoon S
    Oncologist; 2021 Nov; 26(11):916-918. PubMed ID: 34309133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into BRCA Cancer Predisposition from Integrated Germline and Somatic Analyses in 7632 Cancers.
    Yost S; Ruark E; Alexandrov LB; Rahman N
    JNCI Cancer Spectr; 2019 Jun; 3(2):pkz028. PubMed ID: 31360904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Decision-Making in Patients with Variant of Uncertain Significance in BRCA1 or BRCA2 Genes.
    Welsh JL; Hoskin TL; Day CN; Thomas AS; Cogswell JA; Couch FJ; Boughey JC
    Ann Surg Oncol; 2017 Oct; 24(10):3067-3072. PubMed ID: 28766224
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Huszno J; Pigłowski W; Mazur M; Pamuła-Piłat J; Zajkowicz A; Kierzkowska AF; Wojciechowska MO
    Mol Clin Oncol; 2021 Nov; 15(5):222. PubMed ID: 34548921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer.
    Osorio A; de la Hoya M; Rodríguez-López R; Martínez-Ramírez A; Cazorla A; Granizo JJ; Esteller M; Rivas C; Caldés T; Benítez J
    Int J Cancer; 2002 May; 99(2):305-9. PubMed ID: 11979449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
    Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
    Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Clinical Significance of Unknown Sequence Variants in BRCA Genes.
    Calò V; Bruno L; La Paglia L; Perez M; Margarese N; Di Gaudio F; Russo A
    Cancers (Basel); 2010 Sep; 2(3):1644-60. PubMed ID: 24281179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.
    Scherr CL; Lindor NM; Malo TL; Couch FJ; Vadaparampil ST
    Clin Genet; 2015 Dec; 88(6):523-9. PubMed ID: 25640009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically applicable models to characterize BRCA1 and BRCA2 variants of uncertain significance.
    Spearman AD; Sweet K; Zhou XP; McLennan J; Couch FJ; Toland AE
    J Clin Oncol; 2008 Nov; 26(33):5393-400. PubMed ID: 18824701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of PALB2 mutations in 155 Japanese patients with breast and/or ovarian cancer.
    Nakagomi H; Sakamoto I; Hirotsu Y; Amemiya K; Mochiduki H; Omata M
    Int J Clin Oncol; 2016 Apr; 21(2):270-275. PubMed ID: 26411315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From the laboratory to the clinic: sharing BRCA VUS reclassification tools with practicing genetics professionals.
    Augusto BM; Lake P; Scherr CL; Couch FJ; Lindor NM; Vadaparampil ST
    J Community Genet; 2018 Jul; 9(3):209-215. PubMed ID: 29124491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum and management of breast cancer patients with variant of uncertain significance mutations at a tertiary care centre in North India.
    Mittal A; Deo SVS; Gogia A; Batra A; Kumar A; Bhoriwal S; Deb KS; Dhamija E; Ramprasad VL; Olopade O; Pramanik R
    Ecancermedicalscience; 2022; 16():1434. PubMed ID: 36200007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers.
    Federici G; Soddu S
    J Exp Clin Cancer Res; 2020 Mar; 39(1):46. PubMed ID: 32127026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
    Santos C; Peixoto A; Rocha P; Pinto P; Bizarro S; Pinheiro M; Pinto C; Henrique R; Teixeira MR
    J Mol Diagn; 2014 May; 16(3):324-34. PubMed ID: 24607278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
    Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
    Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of the loss of heterozygosity to BRCA1 variant classification.
    Santana Dos Santos E; Spurdle AB; Carraro DM; Briaux A; Southey M; Torrezan G; Petitalot A; Leman R; Lafitte P; ; Meseure D; Driouch K; Side L; Brewer C; Beck S; Melville A; Callaway A; Revillion F; Folgueira MAAK; Parsons MT; Thorne H; Vincent-Salomon A; Stoppa-Lyonnet D; Bieche I; Caputo SM; Rouleau E
    NPJ Breast Cancer; 2022 Jan; 8(1):9. PubMed ID: 35039532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer.
    Lin PH; Kuo WH; Huang AC; Lu YS; Lin CH; Kuo SH; Wang MY; Liu CY; Cheng FT; Yeh MH; Li HY; Yang YH; Hsu YH; Fan SC; Li LY; Yu SL; Chang KJ; Chen PL; Ni YH; Huang CS
    Oncotarget; 2016 Feb; 7(7):8310-20. PubMed ID: 26824983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.